Cargando…
Alendronate Can Improve Bone Alterations in Experimental Diabetes by Preventing Antiosteogenic, Antichondrogenic, and Proadipocytic Effects of AGEs on Bone Marrow Progenitor Cells
Bisphosphonates such as alendronate are antiosteoporotic drugs that inhibit the activity of bone-resorbing osteoclasts and secondarily promote osteoblastic function. Diabetes increases bone-matrix-associated advanced glycation end products (AGEs) that impair bone marrow progenitor cell (BMPC) osteog...
Autores principales: | Chuguransky, Sara Rocío, Cortizo, Ana María, McCarthy, Antonio Desmond |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5093246/ https://www.ncbi.nlm.nih.gov/pubmed/27840829 http://dx.doi.org/10.1155/2016/5891925 |
Ejemplares similares
-
Novel Vanadium-Loaded Ordered Collagen Scaffold Promotes Osteochondral Differentiation of Bone Marrow Progenitor Cells
por: Cortizo, Ana M., et al.
Publicado: (2016) -
Coupling of proadipocyte growth arrest and differentiation. I. Induction by heparinized medium containing human plasma
Publicado: (1982) -
Roles of fibrinolytic factors in the alterations in bone marrow hematopoietic stem/progenitor cells during bone repair
por: Okada, Kiyotaka, et al.
Publicado: (2020) -
Coupling of proadipocyte growth arrest and differentiation. II. A cell cycle model for the physiological control of cell proliferation
Publicado: (1982) -
The Susceptive Alendronate-Treatment Timing and Dosage for Osteogenesis Enhancement in Human Bone Marrow-Derived Stem Cells
por: Chang, Chih-Hsiang, et al.
Publicado: (2014)